Results 21 to 30 of about 448,079 (362)
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature [PDF]
Background Unbalanced chromosomal translocations may present with a variety of clinical and laboratory findings and provide insight into the functions of genes on the involved chromosomal segments.
Meck Jeanne M+5 more
doaj +2 more sources
A Comparison between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients with Congenital Factor VII Deficiency [PDF]
In order to establish the efficacy and biosimilar nature of AryoSeven to NovoSeven in the treatment of congenital factor VII (FVII) deficiency, patients received either agent at 30 1/4g/kg, intravenously per week for 4 weeks, in a randomized fashion. The
Abolghasemi, H.+16 more
core +2 more sources
Acute myeloid leukemia: A rare cause of acquired isolated factor VII deficiency [PDF]
Background: Acquired factor VII deficiency remains a rare pathology. Only 5 prior reported cases of aFVIID associated with acute myeloid leukemia (AML) have been described in the literature.
Zaineb Mlayah+5 more
doaj +2 more sources
Isolated congenital factor VII deficiency [PDF]
Congenital factor VII (FVII) (proconvertin) is a rare autosomal recessive bleeding disorder. Bleeding manifestations and clinical findings vary widely, ranging from being asymptomatic to life-threatening bleeding. Intracranial bleeding is relatively less
Mahalinge, Manisha+5 more
core +4 more sources
Factor VII Deficiency in Systemic Mastocytosis with an Associated Myeloid Neoplasm [PDF]
Factor VII (FVII) deficiency is a rare bleeding disorder that can be classified as congenital or acquired, and the majority of acquired cases are due to vitamin K deficiency or liver disease. Isolated acquired FVII deficiency is a rare occurrence and has
Giorgio Rosati+5 more
doaj +2 more sources
Anticoagulation Therapy Considerations in Factor VII Deficiency [PDF]
Factor VII (FVII) deficiency is the most prevalent rare bleeding disorder in the USA and affects approximately 1 out of every 500,000 people. Warfarin inhibits the synthesis of FVII, in addition to other clotting factors. Warfarin is contraindicated in patients with bleeding tendencies or blood dyscrasias; therefore, the literature regarding the use of
Kathy E. Komperda+3 more
openaire +4 more sources
Chanchai Traivaree,1 Chalinee Monsereenusorn,1 Arunotai Meekaewkunchorn,2 Premsak Laoyookhong,3 Saranya Suwansingh,4 Boonchai Boonyawat5 1Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine ...
Traivaree C+5 more
doaj +2 more sources
Congenital factor VII deficiency [PDF]
R Mandhyan, Alankar Tiwari, G Cherian
openalex +3 more sources
Madhvi Rajpurkar,1 David L Cooper2 1Division of Hematology/Oncology, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children’s Hospital of Michigan, Detroit, MI, USA; 2Clinical, Medical and Regulatory ...
Rajpurkar M, Cooper DL
doaj +2 more sources
Molecular characterization of iranian patients with inherited coagulation factor VII deficiency
Coagulation factor VII (FVII) is a key enzyme of the extrinsic coagulation cascade that is predominantly produced by hepatocytes. The F7 gene mutations cause FVII deficiency with considerable molecular and phenotypic heterogeneity.
Shahbazi S+3 more
doaj +2 more sources